ArticleJACC. Basic to translational science2020

Are the Cardiorenal Benefits of SGLT2 Inhibitors Due to Inhibition of the Sympathetic Nervous System?

Subodh VermaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.